Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
종목 코드 PMI
회사 이름Picard Medical Inc
상장일Aug 29, 2025
CEOSchnegelsberg (Patrick N.J)
직원 수75
유형Ordinary Share
회계 연도 종료Aug 29
주소1992 E. Silverlake Rd.
도시TUCSON
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가United States of America
우편 번호85713
전화15203080796
웹사이트
종목 코드 PMI
상장일Aug 29, 2025
CEOSchnegelsberg (Patrick N.J)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음